Baxter International | GJELD



Debt Endring Dato
Abbott USD 13.24B 883M 2025-03
AtriCure USD 61.86M 8.47M 2025-03
Avanos Medical USD 134.7M 27.3M 2024-12
Baxter International USD 13.13B 191M 2024-12
Becton, Dickinson and Co. USD 18.76B 1.35B 2024-12
Boston Scientific USD 10.75B 139M 2024-12
Cooper Companies USD 2.54B 43.8M 2025-01
Dexcom USD 2.5B 2.1M 2024-12
Edwards Lifesciences USD 597.7M 200K 2024-12
Fresenius EUR 13.28B 40M 2024-12
Globus Medical USD 443.88M 5M 2024-12
Halozyme Therapeutics USD 1.51B 1.64M 2024-12
ICU Medical USD 1.59B 11.36M 2024-12
Insulet USD 1.39B 6.2M 2024-12
Integra LifeSciences USD 1.8B 3.5M 2024-12
Intuitive Surgical USD 0 0 2025-03
J&J USD 52.25B 15.62B 2025-03
Laboratory Of America USD 6.52B 107.7M 2025-03
Masimo USD 765.2M 7.4M 2024-12
Medtronic USD 26.61B 1.72B 2025-01
Merit Medical Systems USD 730.67M 1.12M 2025-03
Quest Diagnostics USD 5.86B 358M 2025-03
Smith & Nephew USD 3.32B 334M 2024-12
Stryker USD 13.6B 1.89B 2024-12
Tandem Diabetes Care USD 354.34M 5.4M 2025-03
Teleflex USD 2B 349.11M 2025-03
Terumo JPY 189.82B 15.02B 2024-12
Zimmer Biomet Holdings USD 6.2B 246.1M 2024-12



Baxter International GJELD - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.